Selective M1 muscarinic agonists: failure of therapeutic strategy against Alzheimer’s disease or inappropriate tactics?

Anavex-1-1666x833.png

Ann Pharm Fr.; 61(3):207-10 Review (French) (2003).

Vamvakides A.


View abstract in PubMed

1/0